- Datum26.04.2024
- Uhrzeit08:00 - 09:00 Uhr
- VeranstalterXTB
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnenSage Therapeutics Inc. Kurse
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (Nasdaq)
Wikifolio
Passender Service zu Sage Therapeutics Inc.
Webinar zu Sage Therapeutics Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)10,920-59,990
- Jahrestief / Hoch ($)10,920-28,260
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Sage Therapeutics Inc.
Termine von Sage Therapeutics Inc.
- Apr25Sage Therapeutics Inc.Q1 2024 Earnings Release
- Aug6Sage Therapeutics Inc.Q2 2024 Earnings Release
- Nov5Sage Therapeutics Inc.Q3 2024 Earnings Release
Beschreibung
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.